Fatemah Basingab

482 total citations
29 papers, 284 citations indexed

About

Fatemah Basingab is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Fatemah Basingab has authored 29 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Fatemah Basingab's work include Autism Spectrum Disorder Research (6 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Fatemah Basingab is often cited by papers focused on Autism Spectrum Disorder Research (6 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Fatemah Basingab collaborates with scholars based in Saudi Arabia, Egypt and Jordan. Fatemah Basingab's co-authors include Hadil Alahdal, Reem Alotaibi, David J. Morgan, Maryam Ahmadi, Alia Aldahlawi, Mona G. Alharbi, Samaa Abdullah, Heba Alkhatabi, Nikos Hadjichristidis and Bothaina A. Alaidaroos and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Fatemah Basingab

23 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatemah Basingab Saudi Arabia 7 102 74 62 43 37 29 284
Mohammad Nasrullah Canada 8 157 1.5× 147 2.0× 161 2.6× 44 1.0× 21 0.6× 19 468
Sarah Bloukh Jordan 7 168 1.6× 63 0.9× 49 0.8× 176 4.1× 122 3.3× 9 572
Ji Ji China 6 71 0.7× 29 0.4× 32 0.5× 25 0.6× 15 0.4× 14 277
Bhavna Lall United States 7 31 0.3× 67 0.9× 34 0.5× 20 0.5× 18 0.5× 11 357
Joel A. Mintz United States 7 22 0.2× 22 0.3× 27 0.4× 45 1.0× 34 0.9× 43 312
Maher Chaar United States 8 29 0.3× 20 0.3× 14 0.2× 64 1.5× 66 1.8× 9 317
Chaohua Li United States 13 42 0.4× 14 0.2× 17 0.3× 70 1.6× 37 1.0× 37 365
Tara A. Schwetz United States 11 32 0.3× 34 0.5× 22 0.4× 227 5.3× 27 0.7× 14 552
Muhammad Abrar Yousaf Pakistan 8 48 0.5× 24 0.3× 16 0.3× 28 0.7× 7 0.2× 23 155
Alberto Lontano Italy 8 20 0.2× 35 0.5× 22 0.4× 20 0.5× 33 0.9× 21 305

Countries citing papers authored by Fatemah Basingab

Since Specialization
Citations

This map shows the geographic impact of Fatemah Basingab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemah Basingab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemah Basingab more than expected).

Fields of papers citing papers by Fatemah Basingab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemah Basingab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemah Basingab. The network helps show where Fatemah Basingab may publish in the future.

Co-authorship network of co-authors of Fatemah Basingab

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemah Basingab. A scholar is included among the top collaborators of Fatemah Basingab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemah Basingab. Fatemah Basingab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aldahlawi, Alia, Mourad Assidi, Fatemah Basingab, et al.. (2025). The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer. Biomolecules. 15(1). 50–50. 1 indexed citations
3.
Aldahlawi, Alia, et al.. (2025). Impact of Chitosan Nanoparticles-Coated Dendritic Cell-Based Vaccine as Cancer Immunotherapy. Vaccines. 13(5). 474–474.
4.
Basingab, Fatemah, et al.. (2025). Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study. International Journal of Molecular Sciences. 26(12). 5468–5468. 1 indexed citations
5.
Basingab, Fatemah, et al.. (2025). From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment. Breast Cancer Targets and Therapy. Volume 17. 27–51. 1 indexed citations
6.
Basingab, Fatemah, et al.. (2024). Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation. Biomedicines. 12(7). 1497–1497.
7.
Basingab, Fatemah, et al.. (2023). Gender Differences in Response to COVID-19 Infection and Vaccination. Biomedicines. 11(6). 1677–1677. 11 indexed citations
8.
Basingab, Fatemah, et al.. (2023). Interaction between Gut Microbiota and Dendritic Cells in Colorectal Cancer. Biomedicines. 11(12). 3196–3196. 4 indexed citations
10.
Aldahlawi, Alia, et al.. (2023). Optimizing the generation of mature bone marrow-derived dendritic cells in vitro: a factorial study design. Journal of Genetic Engineering and Biotechnology. 21(1). 144–144.
11.
Albiheyri, Raed, et al.. (2022). Study the apoptosis and necrosis inducing of fosfomycin into associated infected urothelial tissue by extended spectrum beta lactamase positive of E. coli. Microbial Pathogenesis. 173(Pt A). 105838–105838. 1 indexed citations
12.
Alharbi, Mona G., Magdah Ganash, Fatemah Basingab, et al.. (2022). DNA Methylation Level of Transcription Factor Binding Site in the Promoter Region of Acyl-CoA Synthetase Family Member 3 (ACSF3) in Saudi Autistic Children. SHILAP Revista de lepidopterología. 5 indexed citations
13.
Basingab, Fatemah, et al.. (2022). Alterations in Immune-Related Defensin Alpha 4 (DEFA4) Gene Expression in Health and Disease. International Journal of Inflammation. 2022. 1–15. 7 indexed citations
14.
Abdullah, Samaa, et al.. (2022). Curcumin-betaine solid dispersion for enhancing curcumin dissolution and potentiating pharmacological synergism in gastric cancer cells. Journal of Drug Delivery Science and Technology. 79. 103951–103951. 7 indexed citations
15.
Pushparaj, Peter Natesan, et al.. (2022). Investigating the Changing Levels of Immune Checkpoint Proteins in The Serum of Breast Cancer Patients. Pharmacophore. 13(6). 125–136. 1 indexed citations
16.
Alharbi, Mona G., Magdah Ganash, Fatemah Basingab, et al.. (2022). Multiple Recurrent Copy Number Variations (CNVs) in Chromosome 22 Including 22q11.2 Associated with Autism Spectrum Disorder. Pharmacogenomics and Personalized Medicine. Volume 15. 705–720. 4 indexed citations
17.
Aldahlawi, Alia, et al.. (2021). In vivo evidence: Repression of mucosal immune responses in mice with colon cancer following sustained administration of Streptococcus thermophiles. Saudi Journal of Biological Sciences. 28(8). 4751–4761. 6 indexed citations
18.
Alrafiah, Aziza, et al.. (2021). Effect of e-cigarette flavoring agents on the neural retina of chick embryo: histological and gene expression study. Folia Histochemica et Cytobiologica. 59(4). 245–258. 3 indexed citations
19.
Alahdal, Hadil, Fatemah Basingab, & Reem Alotaibi. (2020). An analytical study on the awareness, attitude and practice during the COVID-19 pandemic in Riyadh, Saudi Arabia. Journal of Infection and Public Health. 13(10). 1446–1452. 161 indexed citations
20.
Basingab, Fatemah, Maryam Ahmadi, & David J. Morgan. (2016). IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses. Cancer Immunology Research. 4(5). 400–411. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026